SAFETY AND EFFICACY OF INTRATUMORAL IPILIMUMAB WITH IV NIVOLUMAB IN METASTATIC MELANOMA. THE NIVIPIT TRIAL

被引：4
|
作者：
Tselikas, Lambros [1 ]
Robert, Caroline [1 ]
Dalle, Stephane [2 ]
Meyer, Nicolas [3 ]
Lebbe, Celeste [4 ]
Ammari, Samy [1 ]
Danlos, Francois-Xavier [1 ]
Roy, Severine [1 ]
Jannin, Camille [1 ]
Farhane, Siham [1 ]
Mourad, Severine [1 ]
Escriou, Guillaume [1 ]
Raoult, Thibault [1 ]
Scoazec, Jean-Yves [1 ]
Texier, Matthieuu [1 ]
Chaput-Gras, Nathalie [1 ]
Zitvogel, Laurence [1 ]
De Baere, Thierry [1 ]
Marabelle, Aurelien [1 ]
机构：
[1] Gustave Roussy, Villejuif, France
[2] Claude Bernard Univ, HCL, Lyon, France
[3] CHU Toulouse, IUCT, Toulouse, France
[4] AP HP, Paris, France
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.277
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
277
引用
收藏
页码：A300 / A300
页数：1
相关论文
共 50 条
  • [1] Phase 1 study to evaluate safety and efficacy of ipilimumab plus nivolumab plus external beam radiotherapy in patients with metastatic melanoma.
    Postow, Michael Andrew
    Knox, Susan Jane
    McCabe, Danielle
    Macri, Mary J.
    Schwarzenberger, Paul
    Ricciardi, Toni
    Ryan, Aileen
    Venhaus, Ralph Rudolph
    Barker, Christopher Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Response rate and safety of standard-dose nivolumab with reduced-dose ipilimumab in metastatic melanoma.
    Mehmi, Inderjit
    Hill, Jordan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [3] Ipilimumab plus temozolomide in metastatic melanoma.
    Patel, S. P.
    Bedikian, A. Y.
    Papadopoulos, N. E.
    Hwu, W.
    Kim, K. B.
    Homsi, J.
    Davies, M. A.
    Woodman, S. E.
    Radvanyi, L. G.
    Woodard, K.
    Mahoney, S.
    Hwu, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] ASSESSMENT OF THE IMMUNOGENICITY OF NIVOLUMAB (NIVO) AND IPILIMUMAB (IPI) IN COMBINATION AND POTENTIAL IMPACT ON SAFETY AND EFFICACY IN PATIENTS WITH ADVANCED MELANOMA.
    Statkevich, P.
    Passey, C.
    Park, J.
    Saeger, S.
    Bello, A.
    Roy, A.
    Agrawal, S.
    Gupta, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 : S9 - S9
  • [5] Clinical characteristics of responders to nivolumab plus ipilimumab (Nivo/Ipi) in metastatic uveal melanoma.
    Shephard, Michael Paul
    Glover, Maura
    Balmes, Gener
    Cain, Suzanne
    Vardeleon, Anna
    Mouton, Rosalind
    Posada, Liberty
    Simien, Rinata
    Hwu, Patrick
    Davies, Michael
    Yee, Cassian
    Wong, Michael
    Tawbi, Hussein
    Woodman, Scott
    Amaria, Rodabe
    Diab, Adi
    Glitza, Isabella
    Hwu, Wen-Jen
    Patel, Sapna
    CANCER RESEARCH, 2020, 80 (19) : 38 - 38
  • [6] Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain
    Mansouri, Alireza
    Moraes, Fabio Y.
    Zadeh, Gelareh
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2177 - 2178
  • [7] Efficacy, Cost and Safety of Ipilimumab in Patients with Metastatic Melanoma Who are not on a Clinical Trial
    Roberts-Thomson, R.
    Perera, T.
    Broadbridge, V.
    Patterson, K.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 72 - 72
  • [8] Phase II Clinical Trial to Assess the Safety and Efficacy of Tocilizumab in Combination with Ipilimumab and Nivolumab for Treatment-naive Metastatic Melanoma
    Abdel-Wahab, Noha
    Montazari, Emma J.
    Spillson, Christine A.
    Bentebibel, Salah-Eddine
    Tayar, Jean H.
    Suarez-Almazor, Maria
    Ekmekcioglu, Suhendan
    Johnson, Daniel H.
    Diab, Adi
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3324 - 3325
  • [9] CHARLI: A phase Ib/II trial of ipilimumab-nivolumab-denosumab or nivolumab-denosumab in patients with unresectable stage III and IV melanoma.
    Lau, Peter Kar Han
    Harris, Samuel John
    Eastgate, Melissa A.
    Kee, Damien
    Mant, Andrew
    Nott, Louise M.
    Gedye, Craig
    Inderjeeth, Andrisha Jade
    Underhill, Craig
    Weppler, Alison Margaret
    Wallace, Roslyn
    Lee, Belinda
    Au-Yeung, George
    Williams, Narelle
    Ospino, Daniel Ariza
    Gonzales, Louise
    Shackleton, Mark J.
    Lo, Serigne N.
    McArthur, Grant A.
    Sandhu, Shahneen
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Phase 1 study to evaluate safety and efficacy of nivolumab (nivo) plus ipilimumab (ipi) plus external beam radiotherapy (RT) in patients with metastatic melanoma.
    Postow, Michael A.
    Knox, Susan Jane
    Goldman, Debra
    Panageas, Katherine
    Halpenny, Darragh
    McCabe, Danielle
    Macri, Mary J.
    Schwarzenberger, Paul
    Ricciardi, Toni
    Ryan, Aileen
    Venhaus, Ralph Rudolph
    Barker, Christopher Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345